Variables | Invasive treatment group | Non-invasive treatment group | ||
---|---|---|---|---|
Correlation coefficient (r) | p-value | Correlation coefficient (r) | p-value | |
LV outflow tract gradient, at rest (mmHg) | − 0.072 | 0.483 | − 0.099 | 0.521 |
LV ejection fraction (%) | − 0.220 | 0.031 | 0.072 | 0.644 |
Interventricular septal thickness (mm) | − 0.208 | 0.042 | − 0.127 | 0.411 |
LV end-diastolic diameter (mm) | 0.262 | 0.010 | 0.377 | 0.012 |
LV posterior wall thickness (mm) | 0.073 | 0.478 | − 0.096 | 0.534 |
Systolic BP (mmHg) | 0.114 | 0.267 | − 0.098 | 0.528 |
Diastolic BP (mmHg) | 0.105 | 0.308 | − 0.028 | 0.858 |
Heart Rate (bpm) | − 0.024 | 0.820 | − 0.081 | 0.599 |
NYHA Class III or IV, n (%) | − 0.038 | 0.710 | − 0.064 | 0.678 |
Atrial fibrillation, n (%) | − 0.015 | 0.885 | − 0.015 | 0.920 |
LDL-C (mmol/L) | − 0.014 | 0.895 | 0.400 | 0.007 |
HDL-C(mmol/L) | − 0.425 |  < 0.001 | − 0.382 | 0.010 |
Cr (µmol/L) | 0.250 | 0.014 | 0.207 | 0.177 |
h-CRP(mg/L) | 0.227 | 0.026 | 0.100 | 0.518 |
NT-proBNP (fmol/mL) | − 0.224 | 0.028 | − 0.224 | 0.028 |
Age | 0.099 | 0.033 | − 0.028 | 0.661 |
BMI | 0.336 |  < 0.001 | 0.168 | 0.271 |